Covid-19: Medsafe grants provisional approval for Pfizer boosters targeting Omicron variants

‘Oku ‘i lalo ha fakamatala faka-Tonga

Medsafe has granted provisional approval for two Pfizer Covid-19 booster vaccines which target Omicron variants BA.1 and BA.4/5.

The vaccine against the Omicron variant of Covid-19 at Tokyo Metropolitan Government Office Building in Shinjuku Ward, Tokyo on October 14, 2022.

Those aged 12 and over who have had at least their first two jabs will be eligible.

But the provisional approval does not mean the vaccines will definitely be used.

In a statement, the Ministry of Health said the Covid-19 Vaccine Technical Advisory Group would now give advice to the government who would then decide whether to use the vaccines.

The recommendations will first be considered by Director-General of Health Diana Sarfati before ministers make a final decision.

If approval is granted, the vaccines are expected to be available in the first quarter of 2023.

The advisory group will also review the eligibility criteria as part of the approval process.

The ministry said the current vaccines in use were still very effective at reducing the risk of serious illness and death, and urged people to ensure they had all the vaccines they were eligible for.

Medsafe’s website showed the provisional approvals for the two new vaccines were granted on 21 December, and are valid until 3 November, 2023.

FAKAMATALA FAKA-TONGA

Kuo foaki ā€˜e he Medsafe ha ngofua fakataimi ā€˜a e huhu maluā€™i pusitā ā€˜a e Pfizer ko ha tāketi ‘eni ke ne fakafepaki’i ā€˜a e fōtunga kehe ā€˜o e ā€˜Omikoloni BA.1 mo e BA.4/5.

Ko kinautolu taā€™u 12 mo ā€˜ova ai pea kuo lava ā€˜enau ā€˜uluaki huhu maluā€™i ā€˜e uaā€™, te nau ā€˜atā ki he pusitā ko ā€˜eniā€™.

Ka ko e ngofua fakataimi ko ā€˜eniā€™ ā€˜oku ā€˜ikai ā€˜uhinga ia ā€˜e pau hano ngāueā€™aki ā€˜a e huhu maluā€™i ko ā€˜eniā€™.

Naā€™e pehē mei he Potungāue Moā€™uiā€™ ā€˜i ha fakamatala ā€˜e fakahoko atu ā€˜e he  Kulupu Covid-19 Vaccine Technical Advisory Group  ā€˜enau faleā€™i ki he puleā€™angaā€™ ke tuā€™unga ai haā€™anau tuā€™utuā€™uni pe ā€˜e ngāueā€™aki ā€˜a e faitoā€™oā€™.

Ko e ngaahi fakahinohinoā€™ ni ā€˜e ā€˜uluaki fakakaukauā€™i ia ā€˜e he Director-General of Health Diana Sarfati  ki muā€™a hano aofangatuku ā€˜e he kau minisitā.

Kapau ā€˜e he tali ā€˜oku ā€˜i ai ā€˜a e ā€˜amanaki ā€˜e faingamālie ā€˜a e huhu maluā€™iā€™ ni ki he ā€˜uluaki kuata ā€˜o e 2023.

ā€˜E toe liviu ā€˜e he kulupu faleā€™i ā€˜a e kulaitelia kia kinautolu ā€˜e kau ki he huhu maluā€™i ā€˜i he faitoā€™o ko ā€˜eni.

Naā€™e pehē ā€˜e he Potungāueā€™ ko e huhu maluā€™i ā€˜oku lolotonga ngāueā€™aki ā€˜oku fuā€™u kei ola lelei ia ā€˜i hono fakasiā€™isiā€™i ā€˜a e lava ke toe puke lahi mo mate ha taha, pea ā€˜oku nau fakalotolahiā€™i ā€˜a e kakaiā€™ ke fakapapauā€™i ke nau fakahoko ā€˜a e ngaahi huhu maluā€™i naā€™e totonu ke maā€™uā€™.

Sometimes when a business is growing, it needs a little help.

Right now Kaniva News provides a free, politically independent, bilingual news service for readers around the world that is absolutely unique. We are the largest New Zealand-based Tongan news service, and our stories reach TongansĀ  wherever they are round the world. But as we grow, there are increased demands on Kaniva News for translation into Tongan on our social media accounts and for the costs associated with expansion. We believe it is important for Tongans to have their own voice and for Tongans to preserve their language, customs and heritage. That is something to which we are strongly committed. Thatā€™s why we are asking you to consider sponsoring our work and helping to preserve a uniquely Tongan point of view for our readers and listeners.

spot_imgspot_imgspot_imgspot_img

Latest news

Related news